Alignment Healthcare, Inc. (NASDAQ: ALHC), an award-winning
Medicare Advantage (MA) company, today announced Jan. 1 health plan
membership of approximately 209,900, representing a 35%
year-over-year increase in health plan membership when compared to
membership as of Jan. 1, 2024. Additionally, the company expects to
have 225,000 to 231,000 health plan members as of Dec. 31,
2025, representing growth of approximately 22% to 25% relative to
the midpoint of its year-end 2024 membership guidance provided on
Oct. 29, 2024.
Furthermore, the company is reaffirming its full-year 2024
guidance ranges on health plan membership, revenue, adjusted gross
profit and adjusted EBITDA provided Oct. 29, 2024. It also
reiterates confidence in attaining consensus adjusted EBITDA of
approximately $40 million in 2025. 2025 guidance will be provided
at its fourth-quarter 2024 earnings call.
“By continuing to put seniors first in everything we do,
Alignment is Medicare Advantage done right,” said John Kao, founder
and CEO. “Another strong year of 35% growth underscores the
effectiveness of our model through a steadfast commitment to
operational excellence and EBITDA performance. Our ability to scale
profitably and achieve solid growth outside of California
demonstrates that we are not just growing – we are winning, and we
are poised to take Alignment to the next level.”
To drive this next phase of growth, Dawn Maroney has
been promoted to President of Alignment Healthcare, Inc., effective
immediately. In this role, she will oversee Alignment’s
day-to-day operations, focusing on optimizing member experiences,
deepening provider engagement and ensuring seamless execution
across all markets. Maroney’s leadership as President of Markets
and CEO of Alignment Health Plan has been instrumental in achieving
record enrollment growth, launching innovative products and
fostering strong partnerships with key stakeholders.
“Dawn has been a cornerstone of Alignment’s success for over a
decade, leading with vision and dedication,” Kao added. “Her
promotion is well-deserved, recognizing her contributions to our
growth and operational excellence. I am confident her leadership as
president will further elevate our member experience, strengthen
provider relationships and optimize market execution, ensuring we
continue scaling profitably while delivering on our mission.”
In 2024, Alignment received numerous recognitions,
including:
- Having 98% of health plan members enrolled in plans rated 4
stars or above for 2025.
- Retaining a 5-star rating from the Centers for Medicare &
Medicaid Services (CMS) for its North Carolina and Nevada HMO
contract for three straight years in 2025, making it one of only
nine plans nationwide to garner the top rating.
- Earning 4.5 stars from CMS for its California PPO in 2025, and
4 stars for its California HMO, marking the HMO’s 8th consecutive
year as a 4-star or greater plan.
- Being named a Newsweek World’s Most Trustworthy Company
2024.
- Earning a 4.9- out of 5-star rating on Google based on more
than 7,000 Google reviews.
“Every milestone we’ve achieved stems from our unwavering focus
on operational excellence and member satisfaction,” Maroney said.
“We believe our approach is helping to restore the promise of MA,
which is to deliver high-quality care and better health outcomes at
lower costs.”
Non-GAAP Measures
Adjusted gross profit is a non-GAAP financial measure that is
presented as supplemental disclosure, that we define as loss from
operations before depreciation and amortization, clinical
equity-based compensation expense, clinical restructuring costs and
selling, general, and administrative expenses. We cannot reconcile
our estimated ranges for adjusted gross profit to loss from
operations, the most directly comparable GAAP measure, and cannot
provide estimated ranges for loss from operations, without
unreasonable efforts because of the uncertainty around certain
items that may impact loss from operations, including equity-based
compensation expense and depreciation and amortization, that are
not within our control or cannot be reasonably predicted.
Adjusted EBITDA is a non-GAAP financial measure that is
presented as supplemental disclosure, that we define as net loss
before interest expense, income taxes, depreciation and
amortization expense, acquisition expenses, certain litigation
costs, gains or losses on right of use ("ROU") assets, gains or
losses on sale of property and equipment, restructuring costs and
equity-based compensation expense. We cannot reconcile our
estimated ranges for Adjusted EBITDA to net loss, the most directly
comparable GAAP measure, and cannot provide estimated ranges for
net loss, without unreasonable efforts because of the uncertainty
around certain items that may impact net loss, including
equity-based compensation expense and depreciation and
amortization, that are not within our control or cannot be
reasonably predicted.
About Alignment HealthcareAlignment
Health is championing a new path in senior care that empowers
members to age well and live their most vibrant lives. A consumer
brand name of Alignment Healthcare (NASDAQ: ALHC),
Alignment Health’s mission-focused team makes high-quality,
low-cost care a reality for its Medicare Advantage members every
day. Based in California, the company partners with nationally
recognized and trusted local providers to deliver coordinated care,
powered by its customized care model, 24/7 concierge care team and
purpose-built technology, AVA®. As it expands its offerings and
grows its national footprint, Alignment upholds its core values of
leading with a serving heart and putting the senior first. For more
information, visit www.alignmenthealth.com.
Forward-Looking StatementsThis release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, and the Private
Securities Litigation Reform Act of 1995, as amended.
Forward-looking statements are subject to risks and uncertainties
and are based on assumptions that may prove to be inaccurate, which
could cause actual results to differ materially from those expected
or implied by the forward-looking statements. Actual results may
differ materially from the results predicted, and reported results
should not be considered as an indication of future performance.
Important risks and uncertainties that could cause our actual
results and financial condition to differ materially from those
indicated in the forward-looking statements include, among others,
the following: our ability to attract new members and enter new
markets, including the need for certain governmental approvals; our
ability to maintain a high rating for our plans on the Five Star
Quality Rating System; our ability to develop and maintain
satisfactory relationships with care providers that service our
members; risks associated with being a government contractor;
changes in laws and regulations applicable to our business model;
risks related to our indebtedness; changes in market or industry
conditions and receptivity to our technology and services; results
of litigation or a security incident; and the impact of shortages
of qualified personnel and related increases in our labor costs.
For a detailed discussion of the risk factors that could
affect our actual results, please refer to the risk factors
identified in our Annual Report on Form 10-K for the year ended
December 31, 2023, and the other periodic reports we file with the
SEC. All information provided in this release and in the
attachments is as of the date hereof, and we undertake no duty to
update or revise this information unless required by law.
Investor ContactHarrison
Zhuohzhuo@ahcusa.com
Media ContactPriya ShahmPR, Inc.
for Alignment Healthcarealignment@mpublicrelations.com
Alignment Healthcare (NASDAQ:ALHC)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
Alignment Healthcare (NASDAQ:ALHC)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025